ResMed Long Term Debt 2010-2025 | RMD

ResMed long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • ResMed long term debt for the quarter ending March 31, 2025 was $0.663B, a 33.49% decline year-over-year.
  • ResMed long term debt for 2024 was $0.697B, a 51.28% decline from 2023.
  • ResMed long term debt for 2023 was $1.431B, a 87.01% increase from 2022.
  • ResMed long term debt for 2022 was $0.765B, a 18.96% increase from 2021.
ResMed Annual Long Term Debt
(Millions of US $)
2024 $697
2023 $1,431
2022 $765
2021 $643
2020 $1,164
2019 $1,259
2018 $270
2017 $1,079
2016 $873
2015 $301
2014 $301
2013 $1
2012 $251
2011 $100
2010 $0
2009 $94
ResMed Quarterly Long Term Debt
(Millions of US $)
2025-03-31 $663
2024-12-31 $663
2024-09-30 $668
2024-06-30 $697
2024-03-31 $997
2023-12-31 $1,217
2023-09-30 $1,352
2023-06-30 $1,431
2023-03-31 $1,576
2022-12-31 $1,791
2022-09-30 $785
2022-06-30 $765
2022-03-31 $669
2021-12-31 $668
2021-09-30 $794
2021-06-30 $643
2021-03-31 $719
2020-12-31 $814
2020-09-30 $1,044
2020-06-30 $1,164
2020-03-31 $1,365
2019-12-31 $1,288
2019-09-30 $1,208
2019-06-30 $1,259
2019-03-31 $1,323
2018-12-31 $1,186
2018-09-30 $518
2018-06-30 $270
2018-03-31 $810
2017-12-31
2017-09-30 $1,019
2017-06-30 $1,079
2017-03-31 $1,168
2016-12-31 $869
2016-09-30 $874
2016-06-30 $873
2016-03-31 $436
2015-12-31 $401
2015-09-30 $501
2015-06-30 $301
2015-03-31 $461
2014-12-31 $450
2014-09-30 $376
2014-06-30 $301
2014-03-31 $396
2013-12-31 $436
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $301
2012-09-30 $266
2012-06-30 $251
2012-03-31 $235
2011-12-31 $225
2011-09-30 $130
2011-06-30 $100
2011-03-31 $80
2010-12-31
2010-09-30
2010-06-30
2010-03-31 $29
2009-12-31 $95
2009-09-30 $95
2009-06-30 $94
2009-03-31 $93
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $35.183B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $231.085B 27.79
Boston Scientific (BSX) US $155.238B 38.86
Stryker (SYK) US $144.362B 30.18
EssilorLuxottica (ESLOY) FR $132.860B 0.00
Medtronic (MDT) IE $108.824B 15.89
Lonza Group Ag (LZAGY) CH $52.624B 0.00
Haleon (HLN) GB $48.259B 27.44
GE HealthCare Technologies (GEHC) US $32.295B 15.33
Agilent Technologies (A) US $30.971B 20.46
Terumo (TRUMY) JP $29.019B 0.00
Koninklijke Philips (PHG) NL $24.053B 17.17
Zimmer Biomet Holdings (ZBH) US $20.255B 12.80
Insulet (PODD) US $18.084B 77.18
Baxter (BAX) US $15.752B 11.77
Smith & Nephew SNATS (SNN) GB $12.535B 0.00
Sunny Optical Technology (SNPTF) CN $9.032B 0.00
Demant (WILYY) DK $7.970B 0.00
Lantheus Holdings (LNTH) US $7.447B 18.31
Bio-Rad Laboratories (BIO) US $6.620B 22.38
Prestige Consumer Healthcare (PBH) US $4.171B 19.90
Perrigo (PRGO) IE $3.497B 10.01
ICU Medical (ICUI) US $3.486B 29.69
Shandong Weigao Medical Polymer (SHWGF) CN $3.459B 0.00
Haemonetics (HAE) US $3.208B 15.10
Envista Holdings (NVST) US $2.880B 23.93
GN Store Nord (GNNDY) DK $2.068B 17.13
QuidelOrtho (QDEL) US $1.964B 16.45
LeMaitre Vascular (LMAT) US $1.778B 39.75
AtriCure (ATRC) US $1.486B 0.00
Green Thumb Industries (GTBIF) US $1.374B 21.63
Neogen (NEOG) US $1.248B 15.97
Kestra Medical Technologies (KMTS) US $1.220B 0.00
BioLife Solutions (BLFS) US $1.200B 0.00
AdaptHealth (AHCO) US $1.184B 11.40
InMode (INMD) IL $1.013B 9.28
Phibro Animal Health (PAHC) US $0.789B 12.10
Evolus (EOLS) US $0.779B 0.00
Curaleaf Holdings (CURLF) CA $0.637B 0.00
CeriBell (CBLL) US $0.588B 0.00
Owens & Minor (OMI) US $0.580B 4.94
Valneva SE (VALN) FR $0.549B 0.00
Capricor Therapeutics (CAPR) US $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) US $0.526B 0.00
Tilray Brands (TLRY) CA $0.458B 0.00
Cresco Labs (CRLBF) US $0.442B 0.00
Omeros (OMER) US $0.418B 0.00
Surmodics (SRDX) US $0.395B 0.00
SNDL (SNDL) CA $0.365B 0.00
VAREX IMAGING (VREX) US $0.359B 15.55
SEMPERIT AG HLD (SEIGY) AT $0.317B 0.00
Verano Holdings (VRNOF) US $0.296B 0.00
Sanara MedTech (SMTI) US $0.292B 0.00
Viemed Healthcare (VMD) US $0.291B 26.32
Aurora Cannabis (ACB) CA $0.272B 48.40
Sanuwave Health (SNWV) US $0.264B 0.00
ZimVie (ZIMV) US $0.261B 15.60
Cerus (CERS) US $0.258B 0.00
Canopy Growth (CGC) CA $0.245B 0.00
Quanterix (QTRX) US $0.233B 0.00
OraSure Technologies (OSUR) US $0.231B 0.00
High Tide (HITI) CA $0.194B 0.00
Biote (BTMD) US $0.190B 4.35
Utah Medical Products (UTMD) US $0.173B 13.93
Brainsway (BWAY) IL $0.170B 53.06
TriSalus Life Sciences (TLSI) US $0.165B 0.00
Organigram Global (OGI) CA $0.154B 0.00
FitLife Brands (FTLF) US $0.148B 18.22
Jin Medical (ZJYL) CN $0.119B 0.00
TerrAscend (TSNDF) CA $0.116B 0.00
MacroGenics (MGNX) US $0.110B 0.00
Exagen (XGN) US $0.108B 0.00
Agape ATP (ATPC) $0.099B 0.00
Oramed Pharmaceuticals (ORMP) US $0.095B 0.00
Quipt Home Medical (QIPT) US $0.094B 0.00
Fonar (FONR) US $0.076B 10.70
Jushi Holdings (JUSHF) US $0.076B 0.00
Veru (VERU) US $0.075B 0.00
InterCure (INCR) IL $0.073B 0.00
Zynex (ZYXI) US $0.070B 0.00
United Health Products (UEEC) US $0.064B 0.00
Cytosorbents (CTSO) US $0.059B 0.00
ImmuCell (ICCC) US $0.048B 0.00
Apyx Medical (APYX) US $0.047B 0.00
Modular Medical (MODD) US $0.042B 0.00
Rockwell Medical (RMTI) US $0.042B 61.50
United-Guardian (UG) US $0.037B 11.28
Safety Shot (SHOT) US $0.036B 0.00
Nephros (NEPH) US $0.020B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) IE $0.015B 0.00
Cellectar Biosciences (CLRB) US $0.012B 0.00
Flora Growth (FLGC) US $0.012B 0.00
Allurion Technologies (ALUR) US $0.011B 0.00
NeuroMetrix (NURO) US $0.009B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.004B 0.00
Senestech (SNES) US $0.004B 0.00
IM Cannabis (IMCC) CA $0.004B 0.00
Akanda (AKAN) GB $0.002B 0.00
Sharps Technology (STSS) US $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00